AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

Kennedy, a vaccine skeptic, has promised sweeping changes to food and drug regulation and government-funded scientific ...

Discover why AstraZeneca's dip and unexpected UK GDP drop impact FTSE 100, as mining stocks rebound amid finance reforms. Get ...

The weaker backdrop means the FTSE 100 index is forecast to give up all yesterday’s rise, with futures pointing to a decline ...

By Samuel Indyk, Ludwig Burger (Reuters) -Shares in global vaccine makers fell sharply on Friday after U.S. President-elect ...

When pharma’s R&D push peaked, hundreds of vaccines and treatments were in development to combat the novel coronavirus. And while the remobilization turned once-obscure biotechs like Moderna into ...